SEP 174559

Drug Profile

SEP 174559

Alternative Names: (S)-desmethylzopiclone; S-desmethylzopiclone; SEP-174559

Latest Information Update: 11 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sepracor
  • Class Anxiolytics
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Muscle spasticity; Spasm

Most Recent Events

  • 22 Aug 2005 This compound is still in active development
  • 10 Oct 2002 A preclinical study has been added to the Anxiety Disorders pharmacodynamics section
  • 19 Sep 2001 Phase-I clinical trials for Anxiety disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top